Cargando…

Androgen-Induced MIG6 Regulates Phosphorylation of Retinoblastoma Protein and AKT to Counteract Non-Genomic AR Signaling in Prostate Cancer Cells

The bipolar androgen therapy (BAT) includes the treatment of prostate cancer (PCa) patients with supraphysiological androgen level (SAL). Interestingly, SAL induces cell senescence in PCa cell lines as well as ex vivo in tumor samples of patients. The SAL-mediated cell senescence was shown to be and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schomann, Tim, Mirzakhani, Kimia, Kallenbach, Julia, Lu, Jing, Rasa, Seyed Mohammad Mahdi, Neri, Francesco, Baniahmad, Aria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405759/ https://www.ncbi.nlm.nih.gov/pubmed/36008945 http://dx.doi.org/10.3390/biom12081048

Ejemplares similares

The androgen receptor—lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells
por: Mirzakhani, Kimia, et al.
Publicado: (2021)

Correction to: The androgen receptor—lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells
por: Mirzakhani, Kimia, et al.
Publicado: (2021)

Protein translation controlled by the androgen receptor in prostate cancer: a novel therapeutic option?
por: Mirzakhani, Kimia, et al.
Publicado: (2020)

A Novel Splice Variant of the Inhibitor of Growth 3 Lacks the Plant Homeodomain and Regulates Epithelial–Mesenchymal Transition in Prostate Cancer Cells
por: Melekhova, Anna, et al.
Publicado: (2021)

Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
por: Kokal, Miriam, et al.
Publicado: (2020)

Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors
por: Bartsch, Sophie, et al.
Publicado: (2021)

Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer
por: Pungsrinont, Thanakorn, et al.
Publicado: (2021)

Interaction between Non-Coding RNAs and Androgen Receptor with an Especial Focus on Prostate Cancer
por: Taheri, Mohammad, et al.
Publicado: (2021)

ING Tumour Suppressors and ING Splice Variants as Coregulators of the Androgen Receptor Signalling in Prostate Cancer
por: Melekhova, Anna, et al.
Publicado: (2021)

Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer
por: Ehsani, Marzieh, et al.
Publicado: (2021)

The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2
por: Ehsani, Marzieh, et al.
Publicado: (2022)

Androgen receptor agonist and antagonist reduce response of cytokine‐induced killer cells on prostate cancer cells
por: Pungsrinont, Thanakorn, et al.
Publicado: (2023)

Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer
por: Kallenbach, Julia, et al.
Publicado: (2022)

Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway
por: Roediger, Julia, et al.
Publicado: (2014)

Combinatorial control of gene expression by the three yeast repressors Mig1, Mig2 and Mig3
por: Westholm, Jakub Orzechowski, et al.
Publicado: (2008)

MIG-7 and phosphorylated prohibitin coordinately regulate lung cancer invasion/metastasis
por: Ho, Ming-Yi, et al.
Publicado: (2014)

MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells
por: Yoo, Jung-Yoon, et al.
Publicado: (2017)

Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
por: Perner, Sven, et al.
Publicado: (2015)

Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer
por: Khan, Farhan, et al.
Publicado: (2023)

MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKT
por: Yoo, Jung-Yoon, et al.
Publicado: (2018)

Diverse roles of androgen receptor (AR) domains in AR-mediated signaling
por: Claessens, Frank, et al.
Publicado: (2008)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

Interleukin-23 Represses the Level of Cell Senescence Induced by the Androgen Receptor Antagonists Enzalutamide and Darolutamide in Castration-Resistant Prostate Cancer Cells
por: Gupta, Siddharth, et al.
Publicado: (2020)

Identification of an AR Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity
por: Hornig, N. C., et al.
Publicado: (2016)

Evaluating glaucoma surgeries in the MIGS context
por: Dhingra, Deepika, et al.
Publicado: (2020)

Roles of Candida albicans Mig1 and Mig2 in glucose repression, pathogenicity traits, and SNF1 essentiality
por: Lagree, Katherine, et al.
Publicado: (2020)

Intervention of AXL in EGFR Signaling via Phosphorylation and Stabilization of MIG6 in Non-Small Cell Lung Cancer
por: Yang, Ya-Yu, et al.
Publicado: (2023)

Androgen receptor (AR) antagonism triggers acute succinate‐mediated adaptive responses to reactivate AR signaling
por: Saxena, Neetu, et al.
Publicado: (2021)

Androgen Plays a Carcinogenic Role in EOC via the PI3K/AKT Signaling Pathway in an AR-Dependent Manner
por: Li, Yanfang, et al.
Publicado: (2021)

A review on the role of long non-coding RNA prostate androgen-regulated transcript 1 (PART1) in the etiology of different disorders
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2023)

Phosphorylation of the androgen receptor at Ser81 is co‐sustained by CDK1 and CDK9 and leads to AR‐mediated transactivation in prostate cancer
por: Gao, XinTao, et al.
Publicado: (2021)

Resistance Exercise Counteracts the Impact of Androgen Deprivation Therapy on Muscle Characteristics in Cancer Patients
por: Overkamp, Maarten, et al.
Publicado: (2023)

Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction
por: Xu, Defeng, et al.
Publicado: (2017)

Human Mig chemokine: biochemical and functional characterization
Publicado: (1995)

Editorial: Epigenetics in prostate cancer
por: Baniahmad, Aria, et al.
Publicado: (2023)

Detection of androgen receptor (AR) and AR-V7 in small cell prostate carcinoma: Diagnostic and therapeutic implications
por: Zhao, Pei, et al.
Publicado: (2019)

Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino‐terminal domain
por: Hua, Yaping, et al.
Publicado: (2018)

Development of a DNA Aptamer for Screening Neisseria meningitidis Serogroup B by Cell SELEX
por: Mirzakhani, Kimia, et al.
Publicado: (2018)

Newt Myotubes Reenter the Cell Cycle by Phosphorylation of the Retinoblastoma Protein
por: Tanaka, Elly M., et al.
Publicado: (1997)

Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells
por: Pungsrinont, Thanakorn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fpg6hlnl985i8sop8u38qq6qbt